Debt-to-equity of Journey Medical Corp from 30 Jun 2022 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Journey Medical Corp quarterly Debt-to-equity in % history and change rate from 30 Jun 2022 to 30 Sep 2025.
  • Journey Medical Corp Debt-to-equity for the quarter ending 30 Sep 2025 was 282%, a 28% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Journey Medical Corp Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 282% -109% -28% 30 Sep 2025
Q2 2025 332% -11% -3.1% 30 Jun 2025
Q1 2025 361% -89% -20% 31 Mar 2025
Q4 2024 400% -182% -31% 31 Dec 2024
Q3 2024 391% -313% -44% 30 Sep 2024
Q2 2024 343% -305% -47% 30 Jun 2024
Q1 2024 451% +56% +14% 31 Mar 2024
Q4 2023 582% +307% +112% 31 Dec 2023
Q3 2023 704% +500% +245% 30 Sep 2023
Q2 2023 648% +353% +120% 30 Jun 2023
Q1 2023 395% 31 Mar 2023
Q4 2022 275% 31 Dec 2022
Q3 2022 204% 30 Sep 2022
Q2 2022 295% 30 Jun 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.